US 11987792
Compositions and methods for inhibiting expression of the LECT2 gene
granted A61KA61K47/02A61K9/0019
Quick answer
US patent 11987792 (Compositions and methods for inhibiting expression of the LECT2 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/02, A61K9/0019, A61K9/08, A61K9/5123